Permits school bus driver to administer epinephrine to student in emergency under certain circumstances.
The enactment of A311 would lead to significant changes in the responsibilities held by school bus drivers. Under the bill, drivers who choose to administer epinephrine will need to undergo proper training, which must be conducted by qualified health professionals. Additionally, the bill stipulates that school districts must develop policies that allow for such emergency interventions while providing written assurances of immunity from liability for both the drivers and the schools, contingent upon specific conditions being met. These measures will likely augment the existing capacity for quick emergency responses to life-threatening allergies on school buses.
Assembly Bill A311 is a legislative proposal aimed at enhancing the health and safety protocols for school transportation in New Jersey. Specifically, the bill allows school bus drivers to administer epinephrine to students experiencing anaphylaxis during emergencies, under strict conditions. This act supplements existing regulations regarding the administration of emergency medication in schools and is primarily aimed at protecting students with severe allergies. The bill is sponsored by Assemblywoman Michele Matsikoudis and is pre-filed for the 2024 session.
While the bill generally has support due to its potential to improve student safety, there may be concerns regarding the additional responsibilities placed on school bus drivers, particularly in terms of training, liability, and emergency preparedness. Critics might argue about the feasibility of expecting bus drivers to handle medical emergencies amidst their primary responsibilities of ensuring safe transportation. Furthermore, issues around the adequacy of training and the clarity of liability exemptions may also arise, necessitating careful consideration in the bill's discussions and eventual implementation.